Skip to content
Sunday, Oct 12, 2025
GRC Times Logo

  • Home
  • Articles
    • Financial Regulations
    • Cybersecurity
    • Cryptocurrency
      • Data Protection
    • Operational Risk
    • AI in GRC
    • HR Compliance
    • Corporate Compliance
    • Reg Change Management
    • Healthcare
      • Pharma Compliance
    • GRC Strategy
      • GRC Insights & Reporting
    • Small Business Compliance
    • Third-Party Risk
  • Regulations & Compliance

Author: GRC Times

GRC Times News Digest October 1, 2025
NewsFeatured NewsFlash News

GRC Times News Digest October 1, 2025

Welcome to today’s GRC Times News Digest — your quick, smart update on governance, risk, and compliance. 🚨 Regulations on…

byGRC Times
HR ComplianceArticlesIntellectual PropertyLegal Compliance

AI in Recruitment : Compliance Revolution in 2025 – A Comprehensive Guide for Employers

Discover essential insights on AI in hiring and the 2025 regulatory updates. Learn how to navigate compliance and the impact of automated recruitment decisions.

byGRC Times
ArticlesCybersecurityData Protection

GDPR Data Protection Officer (DPO) Requirements

In the era of robust privacy regulation, the Data Protection Officer (DPO) plays a critical role in helping organizations comply…

byGRC Times
Automated Risk & Control MonitoringGRC Insights & ReportingGRC ReportsGRC Strategy

E-Discovery Meets Compliance: A Data Tug-of-War

Discover how complianceGRC software addresses e-discovery challenges amidst complex data landscapes and increasing regulatory demands. Explore essential strategies now!

byGRC Times
Cybersecurity

Cybersecurity Regulations Rising as Boardrooms Face Unseen Digital Threat Storm

Cybersecurity regulations rising have thrust vulnerability management into the spotlight as a critical boardroom issue for Australian firms. This article explores how vulnerability management has become a core boardroom priority amid this shifting landscape and what it means for businesses.

byGRC Times
FDA ComplianceHealthcareMarketing

FDA drug promotion rules spotlight compounded meds in Hims & Hers Super Bowl ad controversy

This article unpacks the regulatory framework implicated by the Hims & Hers’ Super Bowl advertisement, explores the implications for the company and the broader pharmaceutical and telehealth industries, and discusses how evolving enforcement trends may shape future drug promotion practices.

byGRC Times

Posts pagination

Previous 1 2 3 4 … 26 Next

Weekly News Roundup

  • About Us
  • Disclaimer
  • DMCA Notice
  • Contact Us

Copyright © 2025 GRC Times | Hyper News by Ascendoor | Powered by WordPress.